Professor Francois Venter

Quick facts

Marketed products

• Atripla · Other
• Truvada · Other

Phase 3 pipeline

• KOCITAF · Infectious Disease
  KOCITAF is a small molecule drug that targets the SARS-CoV-2 virus.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Professor Francois Venter portfolio CI brief
• Professor Francois Venter pipeline updates RSS